Innatus Corporation
Records under this name other than patents Innatus Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Innatus Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,854,717 | Method and compositions for treatment of cancers Lapsed on the fee record Ended Dec 21, 2022 · USPTO record | Lapsed on the fee record | Ended Dec 21, 2022 | USPTO record |
| US 8,197,430 | Method and system to remove cytokine inhibitor in patients Lapsed on the fee record Ended Jun 12, 2020 · USPTO record | Lapsed on the fee record | Ended Jun 12, 2020 | USPTO record |
| US 8,133,490 | Method and system to remove cytokine inhibitors in patients Term ended Term ended Feb 21, 2020 · USPTO record | Term ended | Term ended Feb 21, 2020 | USPTO record |
| US 6,231,536 | Method and compositions for treatments of cancers Term ended Term ended May 21, 2019 · USPTO record | Term ended | Term ended May 21, 2019 | USPTO record |
| US 6,620,382 | Method and compositions for treatment of cancers Term ended Term ended May 22, 2018 · USPTO record | Term ended | Term ended May 22, 2018 | USPTO record |